Novel B-ring modified allocolchicinoids of the NCME series:: Design, synthesis, antimicrotubule activity and cytotoxicity

被引:53
作者
Bergemann, S
Brecht, R
Büttner, F
Guénard, D
Gust, R
Seitz, G
Stubbs, MT
Thoret, S
机构
[1] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany
[2] Free Univ Berlin, Inst Pharm 1, D-14195 Berlin, Germany
[3] Ctr Natl Rech Sci, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France
关键词
D O I
10.1016/S0968-0896(02)00639-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two new series of allocolchicinoids mimicking the structure of (-)-N-acetylcolchinol O-methyl ether (2, NCME) were synthesized and evaluated for their abilities to inhibit tubulin assembly. Possible antitumor properties resulting thereof were evaluated in vitro on the human MCF-7 breast cancer cell line. The first series of NCME-derivatives was brought about by extending the seven membered B-ring to novel semisynthetic variations with a nitrogen containing eight-membered B-ring similar, for example, to the artificial, potent steganacin aza-analogue 3. In the second series the seven-membered B-ring of NCME (2) was modified by annulation with a heterocyclic ring system. The racemic ketone 7a serving as key precursor involved in the syntheses of all the target NCME variants 9-13 and 15, 16 was easily transformed into the eight-membered B-ring lactams 9 and 10 via a Beckmann rearrangement of the corresponding E-oxime 8. The tetrazole annulated congener 11 was prepared via azidotrimethylsilane-mediated Schmidt rearrangement. Treatment of educt 7a with Bredereck's reagent led to the enamino ketone 14, which was easily converted into the pyrazole- or pyrimidine-annulated allocolchicinoids 15 and 16. Remarkably, all the allocolchicinoids 9-13 with an azocin-B-ring affected the tubulin/microtubule equilibrium only moderately. In contrast, the novel heterocycle annulated seven membered B-ring variants 15 and 16 proved to be highly potent tubulin-inhibitory, antimitotic agents. Interaction with tubulin occured at concentrations similar to those observed for colchicine (1) or the lead NCME (2). In all cases the antiproliferative effects correlated roughly with the inhibition of tubulin assembly. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1269 / 1281
页数:13
相关论文
共 41 条
[1]   COMPLETION AND REFINEMENT OF CRYSTAL-STRUCTURES WITH SIR92 [J].
ALTOMARE, A ;
CASCARANO, G ;
GIACOVAZZO, C ;
GUAGLIARDI, A .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 (pt 3) :343-350
[2]  
[Anonymous], 1992, TEXSAN CRYST STRUCT
[3]  
[Anonymous], 1985, TEXSAN CRYST STRUCT
[4]   BICYCLIC AND TRICYCLIC ERGOLINE PARTIAL STRUCTURES - RIGID 3-(2-AMINOETHYL)PYRROLES AND 3-(2-AMINOETHYL)PYRAZOLE AND 4-(2-AMINOETHYL)PYRAZOLE AS DOPAMINE AGONISTS [J].
BACH, NJ ;
KORNFELD, EC ;
JONES, ND ;
CHANEY, MO ;
DORMAN, DE ;
PASCHAL, JW ;
CLEMENS, JA ;
SMALSTIG, EB .
JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (05) :481-491
[5]   Cyclopropyl compounds as chemical building blocks: Total syntheses of the alkaloids (-)-colchicine, imerubrine and grandirubrine [J].
Banwell, MG .
PURE AND APPLIED CHEMISTRY, 1996, 68 (03) :539-542
[6]   Regular sigma-pi organosilane copolymers with alternating oligomeric dimethylsilylene and cis or trans stilbene units [J].
Berger, D ;
Klarner, G ;
Miller, RD .
JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS, 1997, 7 (01) :1-18
[7]   STANDARDIZED KINETIC MICROASSAY TO QUANTIFY DIFFERENTIAL CHEMOSENSITIVITY ON THE BASIS OF PROLIFERATIVE ACTIVITY [J].
BERNHARDT, G ;
REILE, H ;
BIRNBOCK, H ;
SPRUSS, T ;
SCHOENENBERGER, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 118 (01) :35-43
[8]  
Beurskens P. T., 1994, DIRDIF 94 PROGRAM SY
[9]   DEAMINOCOLCHINYL METHYL-ETHER - SYNTHESIS FROM 2,3,4,4'-TETRAMETHOXYBIPHENYL-2-CARBALDEHYDE - COMPARISON OF ANTITUBULIN EFFECTS OF DEAMINOCOLCHINYL METHYL-ETHER AND DEHYDRO ANALOGS [J].
BOYE, O ;
ITOH, Y ;
BROSSI, A .
HELVETICA CHIMICA ACTA, 1989, 72 (08) :1690-1696
[10]  
Boye O., 1992, The Alkaloids, V41, P125